Abstract
Abstract
Background
The Global Initiative for Obstructive Lung Disease (GOLD) staging approach is frequently used to classify the severity of COPD by using spirometry. Recent advancements in artificial intelligence applications enable the automatic identification of COPD severity by chest computer tomography (CT). The goal of this study is to define the role of artificial intelligence in determining the severity of COPD.
Methods
We used a non-contrast CT chest and a computer-aided detection system (Coreline Soft's AVIEW), which was conducted as a descriptive cross sectional study and involved 80 cases. For the diagnosis of parenchymal disease using density mask methods such as inspiratory low attenuation area-950% (%LAA-950 HUINS) and D-value (cluster-size analysis), the spirometry-based Tiffeneau index (TI; calculated as the ratio of forced expiratory volume in the first second (FEV1) to forced vital capacity was used to assess the severity of COPD.
Results
Based on the results of the spirometry, the patients were divided into four groups: mild (n = 23), moderate (n = 39), severe (n = 17), and very severe (n = 1). Insp. LAA-950 (%) in GOLD group 3 was substantially greater than in GOLD groups 2 and 1. Additionally, when compared to groups 2 and 1, the D-value in the GOLD 3 group was significantly higher.
Conclusions
Inspiratory LAA-950% and D-value were found to be significantly related to COPD severity as measured by dyspnea scale and spirometry. Inspiratory LAA-950% was effectively capable of distinguishing between patients with severe and moderate COPD.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference33 articles.
1. Wang S, Summers RM (2012) Machine learning and radiology. Med Image Anal 16(5):933–951
2. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347–365
3. WHO. Chronic obstructive pulmonary disease (COPD): WHO; 2022 [updated 20 May 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
4. Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM (2008) Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma. Int J Chronic Obstr Pulm Dis 3(4):693
5. Heussel C, Herth F, Kappes J, Hantusch R, Hartlieb S, Weinheimer O et al (2009) Fully automatic quantitative assessment of emphysema in computed tomography: comparison with pulmonary function testing and normal values. Eur Radiol 19(10):2391–2402
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献